Joanna M. Watt
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-N1-inosine 5'-monophosphate, Analogues and Early Structure-Activity Relationship.
Journal: Molecules (Basel, Switzerland)
Published: November 08, 2021
Different substrate specificities of the two ADPR binding sites in TRPM2 channels of Nematostella vectensis and the role of IDPR.
Journal: Scientific reports
Published: September 04, 2018
Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers.
Journal: Scientific reports
Published: May 08, 2018
Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease.
Journal: Scientific reports
Published: March 27, 2018
Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis.
Journal: Antioxidants & redox signaling
Published: August 11, 2017
Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 19, 2017
Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".
Journal: Scientific reports
Published: May 26, 2017
Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349.
Journal: The Biochemical journal
Published: January 27, 2017
2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist.
Journal: Nature chemical biology
Published: January 11, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026